Chief Business Officer
CurrentBiomEdit is a biotechnology company focused on product innovation within animal health leveraging synthetic biology and the science of the microbiome. Partnered with Elanco Animal Health and Ginkgo Bioworks to form BiomEdit in May 2022. Launched with a Series A funding raise of $36.5 million with participation from Viking Global Investors, Anterra Capital.